Company intelligence / Profile preview

Bear Stearns

New York City, NY, United Statesbearstearnscompanies.com ↗

Ownership: Private
Employees: ~15000
Development stage: Other

Overview

Bear Stearns was not a life science/biotech/pharma/healthcare company—it was an American investment bank and brokerage firm founded in New York City in1923 that became one of Wall Street’s most prominent institutions before collapsing during the2008 financial crisis due primarily to overexposure to mortgage-backed securities.[1][2] It had no involvement with drug development pipelines or therapeutic modalities typical for companies within biotech/pharma sectors.

The firm ceased operations as an independent entity after being acquired by JPMorgan Chase in March2008.[4]

Industry: Investors

Beyond the preview

Go deeper on Bear Stearns.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bear Stearns.

Explore the full profile